Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9705
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAndayani Adriono, Gitalisa-
dc.contributor.authorRasyid Mahfudz, Sausan-
dc.contributor.authorFauzi Triyoga, Ichsan-
dc.date.accessioned2025-02-21T04:42:32Z-
dc.date.available2025-02-21T04:42:32Z-
dc.date.issued2024-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9705-
dc.description.abstractEales disease is a rare idiopathic occlusive retinal vasculitis with low prevalence in the general population. Its infrequent occurrence limits diagnostic and treatment guidelines, emphasizing the need for ongoing reports to establish effective protocols. This case report describes a patient presenting with symptoms of bilateral retinal vasculitis. Fundus examination revealed vitreous hemorrhage (VH) and peripheral retinal vasculitis. Laboratory and imaging tests were performed to exclude differential diagnoses, leading to Eales disease as the primary diagnosis. Pars plana vitrectomy, panretinal laser photocoagulation, intravitreal anti-vascular endothelial growth factor, and anti-tuberculosis therapy were administered. Long-term follow-up showed satisfactory outcomes. This report suggested Eales disease to be a diagnosis of consideration for ophthalmologists encountering male patients with recurrent VH. Clinical suspicion, including appropriate laboratory testing and imaging, is essential to developing a holistic approach to diagnosis and management, aiming to prevent progression and achieve optimal visual outcomes. KEYWORDS periphlebitis, rare diseases, retinal vasculitis, vitreous hemorrhageen_US
dc.subjectperiphlebitis, rare diseases, retinal vasculitis, vitreous hemorrhageen_US
dc.titleMultimodal approach in the diagnosis and management of Eales disease: a case reporten_US
dc.typeArticleen_US
Appears in Collections:VOL 33 NO 4 (2024)

Files in This Item:
File Description SizeFormat 
258-262.pdf1.62 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.